The dispute is part of a broader U.S.-China tech rivalry, with Europe caught in the middle. Leaders at big carmakers spelled out their worries in the latest round of earnings calls, saying that finding a replacement for Nexperia at scale in the short term will be difficult. Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war against Novo Nordisk.
Author: Boston Herald Wire Services
Published at: 2025-11-08 21:58:59
Still want to read the full version? Full article
